기자가 쓴 기사 더보기
There is an interesting piece of trend tidbit, that the local pharma companies have launched, and been utilizing, "OTC Task Force".
Supposedly, the TF's are aimed to tap the possibility of selling over-the-counter (OTC) drugs in supermarket.
“We are always ready for OTC marketing at supermarkets, if an "appropriate" situation permits,” one company official said.
The government will push for a regulation change to allow OTC drugs to be sold at supermarkets and other distribution channels.
According to officials, the government is positively considering, that allowing such regulatory change would enable people to obtain medicines when pharmacies are closed at night, or when closed on holidays.
Another expectation: This might help bring down the [consumer retail] price of medicines.
According to a report by the Korea Consumer Agency, pharmacies as the sole distribution channel for OTCs is a major reason for the [retail] price bubble in Korea.
The report also stated that the local OTC price might be as much as 250 percent higher than in the United States for some products.
In addition, it pointed out that over-the-counter drugs are widely available at non-pharmaceutical stores in most advanced nations.
Confronted with a grandiose opposition from pharmacists, Japan eased related regulations twice in 1999 and 2004, to allow selected over-the-counter drugs to be sold at other channels.
Also, Japan plans to allow cold medicines and vitamins to be sold over the internet from April next year.
<기사원문>
관련기사에 링크되어 있습니다.
| 인기기사 | 더보기 + |
| 1 | “NMN 암세포 키운다?” 로킷헬스케어 “실험서 확인 안 돼…추측보다 데이터 봐야” |
| 2 | 비체담, ‘BCD101’ 임상 1상 완료…푸에라린 ‘경구화’ 가능성 입증 |
| 3 | 은행잎 추출물, 알츠하이머 치매 원인 ‘베타아밀로이드 응집 억제’ 효과 확인 |
| 4 | "약국이 복지 사각지대 찾는다"…대한약사회, 건강증진위 신설 |
| 5 | [2026 기대되는 신약] ⑨ 유방암 치료제 ‘카미제스트란트’ |
| 6 | AR1001, 9월 톱라인 공개 카운트다운…K바이오 글로벌 상업화 시험대 |
| 7 | 아리바이오, “소룩스와 합병 추진 변함없다” |
| 8 | 노바티스 ‘플루빅토’ PSA 악화 58% 크게 감소 |
| 9 | 한미약품, ‘랩스커버리’ 적용 비만신약 당뇨치료제로 영역 확장 |
| 10 | 휴온스, 휴온스랩 흡수합병…바이오·R&D 경쟁력 강화 |
| 인터뷰 | 더보기 + |
| PEOPLE | 더보기 + |
| 컬쳐/클래시그널 | 더보기 + |
There is an interesting piece of trend tidbit, that the local pharma companies have launched, and been utilizing, "OTC Task Force".
Supposedly, the TF's are aimed to tap the possibility of selling over-the-counter (OTC) drugs in supermarket.
“We are always ready for OTC marketing at supermarkets, if an "appropriate" situation permits,” one company official said.
The government will push for a regulation change to allow OTC drugs to be sold at supermarkets and other distribution channels.
According to officials, the government is positively considering, that allowing such regulatory change would enable people to obtain medicines when pharmacies are closed at night, or when closed on holidays.
Another expectation: This might help bring down the [consumer retail] price of medicines.
According to a report by the Korea Consumer Agency, pharmacies as the sole distribution channel for OTCs is a major reason for the [retail] price bubble in Korea.
The report also stated that the local OTC price might be as much as 250 percent higher than in the United States for some products.
In addition, it pointed out that over-the-counter drugs are widely available at non-pharmaceutical stores in most advanced nations.
Confronted with a grandiose opposition from pharmacists, Japan eased related regulations twice in 1999 and 2004, to allow selected over-the-counter drugs to be sold at other channels.
Also, Japan plans to allow cold medicines and vitamins to be sold over the internet from April next year.
<기사원문>
관련기사에 링크되어 있습니다.